180 Life Sciences Corp [NASDAQ: ATNF] surged by $0.93 during the normal trading session on Monday and reaching a high of $3.48 during the day while it closed the day at $2.81.
180 Life Sciences Corp stock has also gained 212.22% of its value over the past 7 days. However, ATNF stock has inclined by 212.74% in the 3 months of the year. Over the past six months meanwhile, it has gained 77.85% and gained 20.60% year-on date.
The market cap for ATNF stock reached $16.96 million, with 5.19 million shares outstanding and 2.88 million shares in the current float. Compared to the average trading volume of 1.20M shares, ATNF reached a trading volume of 25541040 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about 180 Life Sciences Corp [ATNF]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATNF shares is $1520.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATNF stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for 180 Life Sciences Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 15, 2021.
The Price to Book ratio for the last quarter was 1.89, with the Price to Cash per share for the same quarter was set at 0.62.
ATNF stock trade performance evaluation
180 Life Sciences Corp [ATNF] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 212.22. With this latest performance, ATNF shares gained by 219.28% in over the last four-week period, additionally plugging by 77.85% over the last 6 months – not to mention a rise of 54.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATNF stock in for the last two-week period is set at 91.94, with the RSI for the last a single of trading hit 0.4100, and the three-weeks RSI is set at 0.2400 for 180 Life Sciences Corp [ATNF]. The present Moving Average for the last 50 days of trading for this stock 1.0500, while it was recorded at 1.6600 for the last single week of trading, and 1.6200 for the last 200 days.
180 Life Sciences Corp (ATNF) Capital Structure & Debt Analysis
According to recent financial data for 180 Life Sciences Corp. ( ATNF), the Return on Equity (ROE) stands at -221.23%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -98.96%, reflecting the company’s efficiency in generating profits from its assets. Additionally, 180 Life Sciences Corp’s Return on Invested Capital (ROIC) is -200.79%, showcasing its effectiveness in deploying capital for earnings.
180 Life Sciences Corp (ATNF) Efficiency & Liquidity Metrics
Based on 180 Life Sciences Corp’s (ATNF) latest financial statements, the Debt-to-Equity Ratio is 0.02%, indicating its reliance on debt financing relative to shareholder equity.
180 Life Sciences Corp (ATNF) Efficiency & Liquidity Metrics
From an operational efficiency perspective, 180 Life Sciences Corp. (ATNF) effectively leverages its workforce, generating an average of -$5160000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.02% and a Quick Ratio of 1.02%, indicating strong ability to cover short-term liabilities.
180 Life Sciences Corp [ATNF]: Institutional Ownership
There are presently around $10.39%, or 18.55%% of ATNF stock, in the hands of institutional investors.
